© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Latest Conference Articles
Therapeutic Approaches to Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 17th 2021, 6:00pm
Disease Spotlight: Multiple Sclerosis
Discussing cognitive behavioral therapy for patients with MS, the associate professor of Physical Medicine and Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine mentioned different therapeutic options that can benefit this patient population. [WATCH TIME: 3 minutes]
Anna Kratz, PhD, on Managing MS Fatigue in a Multifaceted Way
November 16th 2021, 10:00pm
Disease Spotlight: Multiple Sclerosis
Anna Kratz, PhD, associate professor of Physical Medicine & Rehabilitation, University of Michigan Medicine, spoke to the benefits of a multifaceted approach to managing fatigue for patients with multiple sclerosis.
Strategies, Tools for Treating Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 16th 2021, 6:00pm
Disease Spotlight: Multiple Sclerosis
The associate professor of Physical Medicine & Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine discussed challenges when addressing fatigue, as well as the need to integrate digital tools for patients with MS. [WATCH TIME: 4 minutes]
Masupirdine Shows Beneficial Effect in Alzheimer Disease Psychosis
November 16th 2021, 12:00pm
Clinical Trials on Alzheimer's Disease Conference
Over 26 weeks of treatment, masupirdine demonstrated a sustained and durable effect on outcomes such as cognition and dementia-related psychosis.
A Multidisciplinary Approach to Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 14th 2021, 10:00am
Disease Spotlight: Multiple Sclerosis
The associate professor of Physical Medicine & Rehabilitation and nonclinical research psychologist at University of Michigan Medicine discussed the complexities of fatigue as a symptom following her presentation at CMCS 2021.
Low-Dose Whole Brain Radiation Therapy Elicits Positive Results in Early Alzheimer Disease Dementia
November 13th 2021, 8:00pm
Clinical Trials on Alzheimer's Disease Conference
A presentation at CTAD 2021 included data from 5 patients enrolled in a phase 2a trial to evaluate neurocognitive, imaging, and safety outcomes of the therapeutic approach in early AD dementia.
Patients With Dementia Willing to Restart Research Participation Interrupted by COVID-19
November 12th 2021, 10:00pm
Clinical Trials on Alzheimer's Disease Conference
Findings presented at CTAD 2021 included data from surveyed participants with dementia and healthy volunteers about starting in-person or remote research.
Evaluating Ocrelizumab in the CHIMES Trial: Mitzi Joi Williams, MD
November 12th 2021, 6:00pm
Disease Spotlight: Multiple Sclerosis
The founder and CEO of Joi Wellness Group Multiple Sclerosis Center described motivations behind the evaluation of ocrelizumab (Ocrevus; Genentech) in minority populations with multiple sclerosis.
National Alzheimer Disease Registry Announced to Collect Clinical Practice Data
November 12th 2021, 4:00pm
Clinical Trials on Alzheimer's Disease Conference
The new registry will collect routine clinical practice data from the care of patients with Alzheimer disease who are taking an FDA-approved disease-modifying therapy.
Autologous Adipose Stem Cells Are Safe in Alzheimer Disease, Slightly Improve Cognitive Function
November 12th 2021, 12:00pm
Clinical Trials on Alzheimer's Disease Conference
Despite the cohort only consisting of 3 patients with Alzheimer disease, autologous cellular therapy data highlighted the potential of the treatment’s results on cognitive assessments such as Montreal Cognitive Assessment.